The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results